Advanced Search

 

Study ID Status Title Patient Level Data
116981 Completed Open, two periods, two treatments, two sequences, cross-over, randomized trial with single dosageof two oral preparations containing 2 mg of Alprazolam (Zamoprax GlaxoSmithKline México, S.A. de C.V. vs. Tafil 2.0 mg, Pharmacia &Upjohn, S.A. de C.V.) in fasting healthy volunteers
116984 Completed Bioequivalence study of an Amoxicillin-Clavulanic Acid Suspension preparation. Cross-over, randomized, single dose, two treatments, two periods and two sequences trial in fasting conditions
116987 Completed A study to evaluate the pharmacokinetics, safety and tolerability, immunogenicity, and pharmacodynamics of GSK2800528 in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
116990 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparation of Cephalexin 125 mg/ 5 ml (Ceporex® GlaxoSmithKline México, S.A. de C.V. vs. Keflex®, Eli Lilly y Compañía de México, S.A. de C.V.) in fasting healthy volunteers
116991 Terminated A Study ROP116991, Clinical Evaluation of 18 to 24mg/day Ropinirole CR for Parkinson’s disease. Study Listed on ClinicalStudyDataRequest.com
116995 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparation of Cephalexin 250 mg/5mL (Ceporex®, GlaxoSmithKline México, S.A. de C.V. vs. Keflex® , Eli Lilly y Compañía de México, S.A. de C.V.) in fasting healthy volunteers
116999 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations containing 1 g of Cephalexin (GlaxoSmithKline México, S.A. de C.V. vs. Keflex® 1g, Eli Lilly y Compañía de México, S.A. de C.V.) in fasting healthy volunteers.
117002 Completed The Clinical and Economic Benefit of Early Avodart Use vs Early Finasteride Use
117003 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations in tablets containing escitalopram 10 mg (product from GlaxoSmithKline México, S.A. de C.V. vs. Lexapro® 10mg, Lundbeck México, S.A. de C.V.) in fasting healthy volunteers
117004 Completed Systematic review and indirect comparison of first line treatments for Human Epidermal Growth Factor Receptor 2 positive (HER2+) advanced or metastatic breast cancer
117006 Completed Drug Treatment Patterns and Survival Among Patients with Metastatic or Recurrent Soft Tissue Sarcoma (m/rSTS) Refractory to at Least One Prior Therapy
117008 Completed An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
117009 Completed A Study to Evaluate the Effect of GSK1265744 150mg Administered Orally Every 12h x 3 Doses on Cardiac Conduction as Assessed by 12-lead Electrocardiogram Compared to Placebo and a Single Oral Dose of Moxifloxacin
117010 Completed Phase I, single-center, open label, fixed-sequence cross-over study to evaluate the effect of rifampin on the pharmacokinetics of oral cabotegravir in healthy subjects
117011 Completed An Open-label Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol when Co-administered with GSK1265744 in Healthy Adult Female Subjects
117012 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations of chewable tablets of Montelukast 5 mg (product of GlaxoSmithKline México, S.A. de C.V. vs. Singulair™, Merck Sharp & Dohme de México, S.A. de C.V.) in fasting healthy volunteers
117014 Completed Efficacy, safety and immunogenicity study of GSK Biologicals’ candidate malaria vaccine 257049 in the sporozoite challenge model in healthy malaria-naïve adults Study Listed on ClinicalStudyDataRequest.com
117015 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations containing Montelukast 10 mg (product of GlaxoSmithKline México, S.A. de C.V. vs. Singulair, Merck Sharp & Dohme de México, S.A. de C.V.)in fasting healthy volunteers
117016 Completed An Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole on the Pharmacokinetics of GSK239512 Study Listed on ClinicalStudyDataRequest.com
117017 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations containing Nimesulide 100 mg(Eskaflam®, GlaxoSmithKline México, S.A. de C.V. vs. Mesulid®, Producto de Roche, S.A. de C.V.) in fasting healthy volunteers
117020 Completed A Two Part, Single-center, Randomized, Open-label, Crossover Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects
117023 Completed A Study to Evaluate the Effect of Age, Food and Gender on Tolerability and Pharmacokinetics of GSK2256294 Following a Single Oral Administration in Healthy Fed and Fasted Elderly Subjects. This Study will also Evaluate the Biliary Metabolites in Healthy Young Males Following a Single Dose of GSK2256294 Study Listed on ClinicalStudyDataRequest.com
117036 Completed Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with GSK Biologicals’ seasonal influenza vaccine GSK2321138A in adults aged 50 years and older
117041 Completed A Phase 1, Open-Label, Randomized, Controlled, Four-Period Crossover Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
117044 Completed Efficacy, safety and tolerability of amoxicillin + clavulanic acid (875mg/125mg) two times a day compared to clindamycin (150mg) four times a day for 5-7 days in treatment of acute odontogenic infection with or without abscess Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.